VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 127 filers reported holding VBI VACCINES INC in Q3 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,788 | -22.5% | 12,500 | 0.0% | 0.00% | – |
Q4 2022 | $4,888 | -45.7% | 12,500 | 0.0% | 0.00% | – |
Q3 2022 | $9,000 | -10.0% | 12,500 | 0.0% | 0.00% | – |
Q2 2022 | $10,000 | -52.4% | 12,500 | 0.0% | 0.00% | – |
Q1 2022 | $21,000 | -41.7% | 12,500 | -18.8% | 0.00% | – |
Q4 2021 | $36,000 | +44.0% | 15,402 | +82.3% | 0.00% | – |
Q3 2021 | $25,000 | +400.0% | 8,448 | +433.0% | 0.00% | – |
Q2 2021 | $5,000 | – | 1,585 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
ArchPoint Investors | 65,000 | $202,000 | 0.06% |
FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
Ergoteles LLC | 171,127 | $532,000 | 0.02% |
J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |